|
BLAC Bellevue Life Sciences Acquisition Corp 1840425 |
| Balance Sheet |
|
Current Assets
|
39,608 |
|
Assets
|
20,925,627 |
|
Current Liabilities
|
3,941,073 |
|
Liabilities
|
26,679,582 |
|
Equity
|
-5,753,955 |
|
Shares Out
|
4,041,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-1,685,040 |
|
Investing Cash Flow
|
16,934,620 |
| Market Analysis |
Market Cap
|
44,008,887 |
|
Price
|
11.35 |
|
BVPS
|
0.20 |
|
PB
|
57.29 |
|
EPS
|
-0.03 |
|
PS
|
9.30 |
|
FCF
|
15,249,580 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view BLAC documents filed with the SEC.
BLAC Filings
Clear
